Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in ...

Merck (known as MDS outside the US and Canada) has announced that Ogsiveo (nirogacestat) has been recommended by the National ...

Treatment with Olumiant resulted in substantial scalp hair regrowth, as well as improvements in eyebrows and eyelashes ...

Healthcare has always been complex, but the pace of change feels greater than ever. Innovation is accelerating, AI is ...

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Pharma Mar’s lurbinectedin (Zepzelca) to treat ...

Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored ...

Eli Lilly and InnoCare Pharma, a biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, have ...

That plurality matters because the strongest answer rarely comes from one point of view, but from several being tested ...

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases ...

If approved, this would be the first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica ...

Join Impetus Digital's pharma-exclusive webinar to discover how compliant AI tools and virtual workflows can elevate static ...